Full name
REVO MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
REVO MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JANA KAROLA MAĆKOWSKIEGO 13, 47-400 RACIBÓRZ
TAX ID6392023966
Rate company:
REVO MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6392023966
KRS0000936831
Share capital5,000.00 zł
address
UL. JANA KAROLA MAĆKOWSKIEGO 13, 47-400 RACIBÓRZ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6392023966
REGON
520611586
KRS
0000936831
Legal form
limited liability company
Register Address
UL. JANA KAROLA MAĆKOWSKIEGO 13, 47-400 RACIBÓRZ
Date of registration in KRS
2021-12-03
Date of commencement of economic activity
2021-12-03
Act signature
RDF/672607/24/0
Pkd codes
86.22.Z - Specialist medical practice activities
68.20.Z - Rental and operating of own or leased real estate
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.21.Z - General medical practice activities
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
exempted
Vat list bank account(s)
PL73 1090 0088 0000 0001 4925 9976 
PL38 1090 0088 0000 0001 4925 9927 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2022 | 2023 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss)  | 266,5 | 258,4 | -3 |
EBITDA | 266,6 | 258,4 | -3,1 |
Short time liabilities | 12 | 393,1 | 3180,2 |
Equity capital | 246,3 | 485,6 | 97,1 |
Operating profit (EBIT) | 266,6 | 258,4 | -3,1 |
Assets | 258,3 | 878,7 | 240,2 |
Net profit (loss) | 241,3 | 238 | -1,4 |
Cash | 253,7 | 97,4 | -61,6 |
Liabilities and provisions for liabilities | 12 | 393,1 | 3180,2 |
Net income from sale | 369,2 | 633,7 | 71,7 |
Working assets | 258,3 | 878,7 | 240,2 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 98 | 49 | -49 |
Equity capital to total assets | 95,4 | 55,3 | -40,1 |
Gross profit margin | 72,2 | 40,8 | -31,4 |
EBITDA Margin | 72,2 | 40,8 | -31,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 12 | 226 | 214 |
Current financial liquidity indicator | 21.556045532226562 | 2.2354748249053955 | -19,4 |
Net dept to EBITDA | -0.9517027735710144 | -0.37707772850990295 | 0,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.